Today, on 8 July, the Annual Report and the Corporate Social Responsibility Report 2013 of JSC Grindeks were submitted to “Nasdaq OMX Riga”.

JSC Grindeks Chairman of the Board Juris Bundulis: “Following the patients’ needs and market trends, Grindeks has achieved significant results in 2013. The company concluded the year of 2013 with turnover of 118.46 million euros and profit of 13.5 million euros. More information about the company’s activities is accessible in the Annual Report and the Corporate Social Responsibility Report 2013”.

The Annual Report 2013 of JSC Grindeks (5 MB)
The Corporate Social Responsibility Report 2013 of JSC Grindeks (2 MB)